This is a general collection of COVID-19 data deposited in the Harvard Dataverse repository. The list in this collection is maintained by the Harvard Dataverse data curation team (IQSS and Harvard Library). Researchers who deposit their related data into Harvard Dataverse will have their data linked to this collection, to increase discoverability of their data. Please use the contact link if you have any questions about this collection.
Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

71 to 80 of 55,989 Results
10_HPRIME_Form10_local FBC_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 29.6 KB - MD5: 96ce37374a40753f65abbebd9e8adec2
11A_HPRIME_Form11A_research renal and liver function_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 30.0 KB - MD5: 842b16a93e971d9d7e2057bbd8b38438
11B_HPRIME_Form11B_local renal and liver function_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 29.0 KB - MD5: 4d5b50955b5e7b3c46855f602da0b5c1
12_HPRIME_Form12_detailed adherence_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 36.4 KB - MD5: addd5d498975e8689233016659a11756
13_HPRIME_Form13_PedsQL_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 27.5 KB - MD5: 430659f41163fc3fee9e0f4904f05699
14A_HPRIME_Form14A_blood slide v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 27.5 KB - MD5: 880f2f5cad85269d5687b5e2d12c447a
14B_HPRIME_Form14B_blood culture v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 25.9 KB - MD5: 1625f7f3c814ad65494a8483483daa87
15_HPRIME_Form15_LTFU and withdrawal v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 27.6 KB - MD5: 7e6591e1087cea01c27bc659dbd137e9
16_HPRIME_Form16_acutely sick visit_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 51.7 KB - MD5: 2425c36df247abb3590eabda67ebbb7a
17_HPRIME_Form 18a_DHA_PQP levels v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 23.2 KB - MD5: 191e074826f87c49c1d90f20c4cf9fae
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.